These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 34696483

  • 1. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC, Holzmayer V, Anderson M, McNamara AL, Sauleda S, Mbanya D, Duong PT, Dung NTT, Cloherty GA.
    Viruses; 2021 Oct 13; 13(10):. PubMed ID: 34696483
    [Abstract] [Full Text] [Related]

  • 2. Incidence of Occult Hepatitis B Infection (OBI) and hepatitis B genotype characterization among blood donors in Cameroon.
    Mbencho MN, Hafza N, Cao LC, Mingo VN, Achidi EA, Ghogomu SM, Velavan TP.
    PLoS One; 2024 Oct 13; 19(10):e0312126. PubMed ID: 39413100
    [Abstract] [Full Text] [Related]

  • 3. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC, McNamara AL, Holzmayer V, Cloherty GA.
    Virol J; 2019 Apr 03; 16(1):43. PubMed ID: 30943997
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O, Bock CT, Kremsner PG, Velavan TP.
    PLoS One; 2015 Apr 03; 10(7):e0131912. PubMed ID: 26148052
    [Abstract] [Full Text] [Related]

  • 6. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S, Balde TAL, Semenov AV, Ostankova YV, Serikova EN, Naidenova EV, Valutite DE, Shchemelev AN, Zueva EB, Esaulenko EV, Totolian AA.
    Vopr Virusol; 2022 Mar 15; 67(1):59-68. PubMed ID: 35293189
    [Abstract] [Full Text] [Related]

  • 7. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL.
    Transfusion; 2021 Jul 15; 61(7):2116-2124. PubMed ID: 33899233
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug 15; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 9. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb 15; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 10. Detection and molecular characterisation of a diagnosis escape variant associated with occult hepatitis B virus in Brazil.
    Almeida RW, Mello FCDA, Menegoy IV, Santo MPDE, Ginuíno CF, Sousa PSF, Villar LM, Lampe E, Lewis-Ximenez LL.
    Mem Inst Oswaldo Cruz; 2017 Jul 15; 112(7):485-491. PubMed ID: 28591309
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M, Tinguely C, Fontana S, Niederhauser C.
    Transfusion; 2014 Nov 15; 54(11):2961-7. PubMed ID: 24805974
    [Abstract] [Full Text] [Related]

  • 12. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC, Busch MP.
    Mol Diagn Ther; 2006 Nov 15; 10(2):77-91. PubMed ID: 16669606
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H.
    J Med Virol; 2001 Jul 15; 64(3):312-9. PubMed ID: 11424120
    [Abstract] [Full Text] [Related]

  • 14. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct 15; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

  • 15. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 15; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 16. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb 15; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 17. Does the ultrasensitive HBsAg Next assay enhance Hepatitis B diagnosis? An evaluation of analytical performances.
    Bourdin J, Sellier P, Salmona M, Lascoux-Combe C, Delaugerre C, Maylin S.
    J Clin Virol; 2024 Oct 15; 174():105707. PubMed ID: 38964144
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of individual donor nucleic acid testing (NAT) for the detection of hepatitis B infection by studying diluted NAT yield samples.
    Arora S, Doda V, Kirtania T.
    Blood Transfus; 2015 Apr 15; 13(2):227-32. PubMed ID: 25369612
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr 15; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 20. Detection of hepatitis B virus infection in German blood donors 2008-2015.
    Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M.
    Vox Sang; 2020 Apr 15; 115(3):152-161. PubMed ID: 32023664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.